Disfunción miocárdica en la sepsis

Myocardial dysfunction appears in 25% of patients with severe sepsis and in 50% of patients with septic shock, even in the presence of hyper dynamic states. It is characterized by a reduction in left ventricle ejection fraction, that reverts at the seventh to tenth day of evolution. Right ventricular dysfunction and diastolic left ventricular dysfunction can also appear. There is no consensus if an increase in end diastolic volume is part of the syndrome. High troponin or brain natriuretic peptide levels are associated with myocardial dysfunction and a higher mortality. The pathogenesis of myocardial dysfunction is related to micro and macro circulatory changes, infammatory response, oxidative stress, intracellular calcium management disturbances, metabolic changes, autonomic dysfunction, activation of apoptosis, mitochondrial abnormalities and a derangement in catecholaminergic stimulation. Since there is no specifc treatment for myocardial dysfunction, its management requires an adequate multi systemic support to maintain perfusion pressures and systemic fows suffcient for the regional and global demands.

Saved in:
Bibliographic Details
Main Authors: ANDRESEN,MAX, REGUEIRA,TOMÁS
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2010
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000700015
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872010000700015
record_format ojs
spelling oai:scielo:S0034-988720100007000152010-11-26Disfunción miocárdica en la sepsisANDRESEN,MAXREGUEIRA,TOMÁS Cardiomyopathies Heart failure Sepsis Myocardial dysfunction appears in 25% of patients with severe sepsis and in 50% of patients with septic shock, even in the presence of hyper dynamic states. It is characterized by a reduction in left ventricle ejection fraction, that reverts at the seventh to tenth day of evolution. Right ventricular dysfunction and diastolic left ventricular dysfunction can also appear. There is no consensus if an increase in end diastolic volume is part of the syndrome. High troponin or brain natriuretic peptide levels are associated with myocardial dysfunction and a higher mortality. The pathogenesis of myocardial dysfunction is related to micro and macro circulatory changes, infammatory response, oxidative stress, intracellular calcium management disturbances, metabolic changes, autonomic dysfunction, activation of apoptosis, mitochondrial abnormalities and a derangement in catecholaminergic stimulation. Since there is no specifc treatment for myocardial dysfunction, its management requires an adequate multi systemic support to maintain perfusion pressures and systemic fows suffcient for the regional and global demands.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.138 n.7 20102010-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000700015es10.4067/S0034-98872010000700015
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author ANDRESEN,MAX
REGUEIRA,TOMÁS
spellingShingle ANDRESEN,MAX
REGUEIRA,TOMÁS
Disfunción miocárdica en la sepsis
author_facet ANDRESEN,MAX
REGUEIRA,TOMÁS
author_sort ANDRESEN,MAX
title Disfunción miocárdica en la sepsis
title_short Disfunción miocárdica en la sepsis
title_full Disfunción miocárdica en la sepsis
title_fullStr Disfunción miocárdica en la sepsis
title_full_unstemmed Disfunción miocárdica en la sepsis
title_sort disfunción miocárdica en la sepsis
description Myocardial dysfunction appears in 25% of patients with severe sepsis and in 50% of patients with septic shock, even in the presence of hyper dynamic states. It is characterized by a reduction in left ventricle ejection fraction, that reverts at the seventh to tenth day of evolution. Right ventricular dysfunction and diastolic left ventricular dysfunction can also appear. There is no consensus if an increase in end diastolic volume is part of the syndrome. High troponin or brain natriuretic peptide levels are associated with myocardial dysfunction and a higher mortality. The pathogenesis of myocardial dysfunction is related to micro and macro circulatory changes, infammatory response, oxidative stress, intracellular calcium management disturbances, metabolic changes, autonomic dysfunction, activation of apoptosis, mitochondrial abnormalities and a derangement in catecholaminergic stimulation. Since there is no specifc treatment for myocardial dysfunction, its management requires an adequate multi systemic support to maintain perfusion pressures and systemic fows suffcient for the regional and global demands.
publisher Sociedad Médica de Santiago
publishDate 2010
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000700015
work_keys_str_mv AT andresenmax disfuncionmiocardicaenlasepsis
AT regueiratomas disfuncionmiocardicaenlasepsis
_version_ 1755988328041152512